---
layout: post
title: "Advances in Bone Repair: A Bioengineered PMMA-Based Bone Cement with Enhanced Otseoconductivity Utilizing Human-Derived Bone Powder"
authors: "Adel Marzban"
journal: "Journal of Polymers and the Environment"
categories: [Allograft, Bone Cement, Biomaterials, Calcium-based cement]
year: 2025
doi: "[https://onlinelibrary.wiley.com/doi/10.1002/cjce.23048]](https://doi.org/10.1007/s10924-025-03573-w"
pdf: "{{ site.baseurl }}/assets/pdfs/marzban-2025-dn-hydrogel.pdf"
abstract: "This study introduces a bioengineered PMMA-based bone cement reinforced with chitosan and human-derived bone powder, achieving enhanced osteoconductivity, improved mechanical strength, reduced polymerization temperature, and superior cellular responses compared to conventional PMMA."
---

**Highlights**
This publication focuses on overcoming key limitations of conventional polymethyl methacrylate (PMMA) bone cement, including its poor bioactivity, relatively high polymerization heat, and restricted mechanical performance. The authors develop a modified cement formulation by incorporating chitosan (Ch) and human-derived allograft bone powder (BP), both chosen for their bioactive and osteoconductive properties. The composite PMMA-Ch-BP cement is fabricated via solvent casting, and its structure and morphology are characterized using FTIR and SEM. Mechanical testing reveals a notable 26.77% increase in compressive strength relative to standard PMMA, while a 15.22 Â°C decrease in polymerization temperature suggests a reduced risk of thermal damage to surrounding tissues. In vitro assays demonstrate enhanced biocompatibility, with the modified cement reaching approximately 120% cell viability versus unmodified PMMA by day 5, alongside improved cell attachment and spreading observed in SEM imaging. Overall, the results indicate that PMMA-Ch-BP is a promising next-generation bone cement with superior osteoconductive potential, better mechanical performance, and safer thermal behavior for orthopedic applications.
